Your browser doesn't support javascript.
loading
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer.
Galsky, Matthew D; Balar, Arjun V; Black, Peter C; Campbell, Matthew T; Dykstra, Gail S; Grivas, Petros; Gupta, Shilpa; Hoimes, Christoper J; Lopez, Lidia P; Meeks, Joshua J; Plimack, Elizabeth R; Rosenberg, Jonathan E; Shore, Neal; Steinberg, Gary D; Kamat, Ashish M.
Afiliación
  • Galsky MD; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Balar AV; Perlmutter Cancer Center, New York University Langone Medical Center, New York, New York, USA.
  • Black PC; Department of Urologic Sciences, The University of British Columbia, Vancouver, British Columbia, Canada.
  • Campbell MT; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Dykstra GS; Bladder Cancer Advocacy Network (BCAN), Bethesda, Maryland, USA.
  • Grivas P; Dykstra Research, Seattle, Washington, USA.
  • Gupta S; Department of Medicine, Division of Oncology, University of Washington, Seattle, Washington, USA.
  • Hoimes CJ; Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Lopez LP; Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.
  • Meeks JJ; Department of Medicine, Duke Cancer Institute, Duke University, Durham, North Carolina, USA.
  • Plimack ER; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, California, USA.
  • Rosenberg JE; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Shore N; The Jesse Brown VA Medical Center, Chicago, Illinois, USA.
  • Steinberg GD; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Kamat AM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
J Immunother Cancer ; 9(7)2021 07.
Article en En | MEDLINE | ID: mdl-34266883
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sociedades Médicas / Neoplasias de la Vejiga Urinaria / Inmunoterapia Tipo de estudio: Guideline / Prognostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sociedades Médicas / Neoplasias de la Vejiga Urinaria / Inmunoterapia Tipo de estudio: Guideline / Prognostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido